Abstract

The management of pericardial diseases is largely empirical because of the relative lack of randomized trials that involve patients with these conditions. A first attempt to bring together and organize current knowledge resulted in the publication of the first guidelines on the management of pericardial diseases. Nevertheless, a number of observational studies and the first randomized trials are moving the management of pericardial diseases towards evidence-based medicine, particularly for pericarditis. Emerging data indicate that management can be tailored to the individual patient and, although the optimal duration of treatment is not clearly established, some recommendations can be formulated to guide management and follow-up.

Author affiliations

M. Imazio, A. Brucato, R. Trinchero & Y. Adler
Cardiology Department, Maria Vittoria Hospital, Torino, Italy (M. Imazio, R. Trinchero). Department of Internal Medicine, Ospedali Riuniti, Bergamo, Italy (A. Brucato). Cardiac Rehabilitation Institute, Chaim Sheba Medical Center, Tel-Hashomer and Sackler Faculty of Medicine, Tel-Aviv and Misgav Ladach Hospital, Jerusalem, Kupat Holim Meuhedet, Israel (Y. Adler).

Correspondence to: M. Imazio massimo_imazio@yahoo.it

Published online 27 October 2009